BARBARA PESCITELLI: Open Payments
NPI 1154398154 · GREENFIELD, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$989 in 48 payments from 21 companies in 2025. Trend: 2023 $806 · 2024 $791 · 2025 $989
Food & beverage: $989
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 8 | $153 |
| Regeneron Healthcare Solutions, Inc. | 5 | $115 |
| Grifols USA, LLC | 3 | $89 |
| Astellas Pharma US Inc | 3 | $67 |
| Exact Sciences Corporation | 4 | $65 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $57 |
| GlaxoSmithKline, LLC. | 3 | $51 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $51 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| Baxter Healthcare | 2 | $48 |
Products named: DUPIXENT, Prolastin-C Liquid, Veozah, GLASSIA, The Cologuard Plus Collection Kit, Hillrom - Monarch Airway Clearance System, TRELEGY ELLIPTA, Vest Therapy Und.
Industry payments across IN — which companies pay providers there.
